These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34390273)
1. Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study. Campillo JT; Eiden C; Boussinesq M; Pion SDS; Faillie JL; Chesnais CB Br J Clin Pharmacol; 2022 Mar; 88(3):1094-1106. PubMed ID: 34390273 [TBL] [Abstract][Full Text] [Related]
2. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554 [TBL] [Abstract][Full Text] [Related]
3. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database. Lee S; Lee K; Park J; Jeong YD; Jo H; Kim S; Woo S; Son Y; Kim HJ; Lee K; Ha Y; Oh NE; Lee J; Rhee SY; Smith L; Kang J; Rahmati M; Lee H; Yon DK J Med Virol; 2024 Jul; 96(7):e29792. PubMed ID: 38993028 [TBL] [Abstract][Full Text] [Related]
4. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771 [TBL] [Abstract][Full Text] [Related]
5. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
6. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356 [TBL] [Abstract][Full Text] [Related]
7. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
8. Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019. Montastruc JL Br J Clin Pharmacol; 2023 Jan; 89(1):201-208. PubMed ID: 35881623 [TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302 [TBL] [Abstract][Full Text] [Related]
10. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis. Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078 [TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years. Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417 [TBL] [Abstract][Full Text] [Related]
12. Psychiatric adverse drug reactions in the paediatric population. Ekhart C; Vries T; Hunsel FV Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030 [TBL] [Abstract][Full Text] [Related]
13. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme. Masuka JT; Khoza S Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524 [TBL] [Abstract][Full Text] [Related]
14. Paradoxical adverse drug reactions: descriptive analysis of French reports. Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024 [TBL] [Abstract][Full Text] [Related]
15. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073 [TBL] [Abstract][Full Text] [Related]
16. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109 [TBL] [Abstract][Full Text] [Related]
17. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®. Svendsen K; Wood M; Olsson E; Nordeng H Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074 [TBL] [Abstract][Full Text] [Related]
18. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896 [TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567 [TBL] [Abstract][Full Text] [Related]
20. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011. Aagaard L; Hansen EH Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]